These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28849427)

  • 1. Overexpression of cytosolic, plasma membrane bound and extracellular heat shock protein 70 (Hsp70) in primary glioblastomas.
    Thorsteinsdottir J; Stangl S; Fu P; Guo K; Albrecht V; Eigenbrod S; Erl J; Gehrmann M; Tonn JC; Multhoff G; Schichor C
    J Neurooncol; 2017 Dec; 135(3):443-452. PubMed ID: 28849427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical and Flow Cytometric Analysis of Intracellular and Membrane-Bound Hsp70, as a Putative Biomarker of Glioblastoma Multiforme, Using the cmHsp70.1 Monoclonal Antibody.
    Stangl S; Foulds GA; Fellinger H; Pilkington GJ; Pockley AG; Multhoff G
    Methods Mol Biol; 2018; 1709():307-320. PubMed ID: 29177668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
    Roodakker KR; Elsir T; Edqvist PD; Hägerstrand D; Carlson J; Lysiak M; Henriksson R; Pontén F; Rosell J; Söderkvist P; Stupp R; Tchougounova E; Nistér M; Malmström A; Smits A
    Oncotarget; 2016 Nov; 7(45):72431-72442. PubMed ID: 27626492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
    Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Hedgehog pathway responsive glioblastomas by isocitrate dehydrogenase mutation.
    Gerardo Valadez J; Grover VK; Carter MD; Calcutt MW; Abiria SA; Lundberg CJ; Williams TV; Cooper MK
    Cancer Lett; 2013 Jan; 328(2):297-306. PubMed ID: 23063752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma.
    Lämmer F; Delbridge C; Würstle S; Neff F; Meyer B; Schlegel J; Kessel KA; Schmid TE; Schilling D; Combs SE
    PLoS One; 2019; 14(8):e0221502. PubMed ID: 31430337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary glioblastoma multiforme tumors and recurrence : Comparative analysis of the danger signals HMGB1, HSP70, and calreticulin.
    Muth C; Rubner Y; Semrau S; Rühle PF; Frey B; Strnad A; Buslei R; Fietkau R; Gaipl US
    Strahlenther Onkol; 2016 Mar; 192(3):146-55. PubMed ID: 26646311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical, Flow Cytometric, and ELISA-Based Analyses of Intracellular, Membrane-Expressed, and Extracellular Hsp70 as Cancer Biomarkers.
    Dezfouli AB; Stangl S; Foulds GA; Lennartz P; Pilkington GJ; Pockley AG; Multhoff G
    Methods Mol Biol; 2023; 2693():307-324. PubMed ID: 37540444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy.
    Tamura K; Aoyagi M; Ando N; Ogishima T; Wakimoto H; Yamamoto M; Ohno K
    J Neurosurg; 2013 Nov; 119(5):1145-55. PubMed ID: 23991844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necrogenesis and Fas/APO-1 (CD95) expression in primary (de novo) and secondary glioblastomas.
    Tohma Y; Gratas C; Van Meir EG; Desbaillets I; Tenan M; Tachibana O; Kleihues P; Ohgaki H
    J Neuropathol Exp Neurol; 1998 Mar; 57(3):239-45. PubMed ID: 9600216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and prognostic value of JAM-A in gliomas.
    Rosager AM; Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Lathia JD; Kristensen BW
    J Neurooncol; 2017 Oct; 135(1):107-117. PubMed ID: 28677106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential up-regulation of cytosolic and membrane-bound heat shock protein 70 in tumor cells by anti-inflammatory drugs.
    Gehrmann M; Brunner M; Pfister K; Reichle A; Kremmer E; Multhoff G
    Clin Cancer Res; 2004 May; 10(10):3354-64. PubMed ID: 15161689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
    Beier D; Hau P; Proescholdt M; Lohmeier A; Wischhusen J; Oefner PJ; Aigner L; Brawanski A; Bogdahn U; Beier CP
    Cancer Res; 2007 May; 67(9):4010-5. PubMed ID: 17483311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of nestin suppresses stem cell phenotype of glioblastomas through the alteration of post-translational modification of heat shock protein HSPA8/HSC71.
    Matsuda Y; Ishiwata T; Yoshimura H; Hagio M; Arai T
    Cancer Lett; 2015 Feb; 357(2):602-11. PubMed ID: 25527454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD166/activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion.
    Kijima N; Hosen N; Kagawa N; Hashimoto N; Nakano A; Fujimoto Y; Kinoshita M; Sugiyama H; Yoshimine T
    Neuro Oncol; 2012 Oct; 14(10):1254-64. PubMed ID: 22166264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas.
    Cassoni P; Senetta R; Castellano I; Ortolan E; Bosco M; Magnani I; Ducati A
    Am J Surg Pathol; 2007 May; 31(5):760-9. PubMed ID: 17460461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis.
    Yan W; Li R; Liu Y; Yang P; Wang Z; Zhang C; Bao Z; Zhang W; You Y; Jiang T
    Oncotarget; 2014 Dec; 5(24):12908-15. PubMed ID: 25415048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastoma.
    Agnihotri S; Aldape KD; Zadeh G
    Neurosurg Focus; 2014 Dec; 37(6):E13. PubMed ID: 25434382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor.
    Kodama T; Ikeda E; Okada A; Ohtsuka T; Shimoda M; Shiomi T; Yoshida K; Nakada M; Ohuchi E; Okada Y
    Am J Pathol; 2004 Nov; 165(5):1743-53. PubMed ID: 15509542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.